Visceral fat / lipolysis Tesamorelin is FDA-approved to reduce visceral adipose tissue in HIV-associated lipodystrophy
Funding This work was supported by the start-up funds for research from China Medical University (110/1210616002)
When to Consider Peptide Therapy (and When Not To) Peptides May Be Right If You: Struggle with recovery , fatigue, or muscle loss Are over 40 and experiencing age-related decline Have recurring joint pain or slow-healing injuries Want a natural alternative to HGH or NSAIDs You Should Avoid Peptides If: You have a history of cancer (especially hormone-sensitive types) You are pregnant or breastfeeding You have untreated autoimmune disease We take a conservative approachensuring every patient is screened, monitored, and educated
PARP competition : In theory, high DNA-damage states may cause rapid NAD+ depletion even with supplementation
Prof Ranjan K Singh is thankful to DST- FIST programme, and ongoing BHU IOE scheme for financial support

Product Highlights 10 mL sterile pharmaceutical-grade nasal spray ~100 sprays per bottle Each spray delivers 0.1 mL 100 mcg total peptide ~50 mcg BPC-157 ~50 mcg TB-500 Total peptide content: 10 mg (5 mg BPC-157 + 5 mg TB-500) Optimized isotonic nasal vehicle for smooth absorption Designed to avoid irritation, dryness, or burning sensation Filled in Class A, lead-free pharmaceutical glass Child-resistant / tamper-proof cap + orifice reducer Preservative-free, high-purity research formulation Benefits Studied for accelerated soft-tissue and cellular repair Explored for tendon, ligament, and muscular healing pathways Research interest in angiogenesis and microcirculation improvement Cytoprotective effects in inflammatory models Potential synergy between BPC-157 + TB-500 in recovery studies Interest in gut, connective-tissue, and neurological resilience Localized Nasal Delivery Effects Rapid mucosal uptake Faster systemic availability in research models Avoids the need for injection-based delivery Smooth, non-irritating isotonic formulation What Researchers Use It For Anti-inflammatory & cytoprotective signaling Angiogenesis and vascular repair modeling Tissue recovery under strain, injury, or oxidative stress Synergistic peptide activity between BPC-157 & TB-500 Regenerative peptide research involving ECM remodeling Identity & Specs BPC-157 (5 mg) Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Formula / M.W.: C62H98N16O22 ~1419.5 g/mol CAS: 137525-51-0 TB-500 (5 mg) (Thymosin Beta-4 fragment) Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Thr-Glu-Glu-Ala-Gln-Gly-Gln-Ala-Gln Formula / M.W.: ~4963 g/mol (varies by analog fragment form) CAS: N/A (fragment analog) General Specs Form: Sterile nasal spray solution Net per vial: 10 mL (~100 sprays) Total Content: 5 mg BPC-157 + 5 mg TB-500 Purity: 99% (HPLC) Identity: MS-verified (per COA) Storage: Refrigerate 28 C, protect from light Selected Research BPC-157 TB-500 / Thymosin Beta-4 Fragment Disclaimer This product is intended for laboratory research use only
